Lenvima Capsule
Product Images NDC 62856-708

Product Visual Gallery

This gallery contains 25 technical images submitted to the FDA as part of the official labeling for Lenvima (NDC 62856-708). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eisai Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Chemical Structure Of Lenvatinib Mesylate Is Lenvima, A Kinase Inhibitor, Is The Mesylate Salt Of Lenvatinib. Its Chemical Name Is 4-[3-chloro-4-(n’-cyclopropylureido)phenoxy]-7-methoxyquinoline-6 Carboxamide Methanesulfonate. The Molecular Formula Is C21h19cln4o4 • Ch4o3s, And The Molecular Weight Of The Mesylate Salt Is 522.96. (Lenvima 01)

FDA Label Image

Figure 1: Kaplan-meier Curves For Progression-free Survival In (Lenvima 02)

FDA Label Image

Figure 2: Kaplan-meier Curves For Progression-free Survival In Study 205 (Lenvima 03)

FDA Label Image

Figure 3: Kaplan-meier Curves For Overall Survival In Study 205 (Lenvima 04)

FDA Label Image

Figure 4: Kaplan-meier Curves For Overall Survival In Reflect (Lenvima 05)

This is a list of medications and dosages. It includes Everolimus at 10mg and a combination of Lenvima (18mg) and Everolimus (Smg), along with other unclear information about subjects and subgroups. There is not enough information to provide further context.*

FDA Label Image

Principal Display Panelndc 62856-704-30lenvima(lenvatinib) Capsules4 mg Daily Dose (Lenvima 06)

FDA Label Image

Principal Display Panelndc 62856-708-05lenvima(lenvatinib) Capsules8 mg Daily Dose (Lenvima 07)

FDA Label Image

Principal Display Panelndc 62856-710-30lenvima(lenvatinib) Capsules10 mg Daily Dose30 Day Supply10 mg Daily- Dose Carton Containing 6 Cards (Lenvima 08)

FDA Label Image

Principal Display Panelndc 62856-712-30lenvima(lenvatinib) Capsules12 mg Daily Dose (Lenvima 09)

FDA Label Image

Principal Display Panelndc 62856-714-30lenvima(lenvatinib) Capsules14 mg Daily Dose30 Day Supply14 mg Daily- Dose Carton Containing 6 Cards (Lenvima 0a)

This appears to be a description of a medication called Lenvima, containing 4mg capsules. The package shown contains a 30 day supply and a daily dose is recommended. However, there is no additional information available due to the incomplete and unreadable nature of the text.*

FDA Label Image

Principal Display Panelndc 62856-718-30lenvima(lenvatinib) Capsules18 mg Daily Dose (Lenvima 0b)

FDA Label Image

Principal Display Panelndc 62856-720-30lenvima(lenvatinib) Capsules20 mg Daily Dose30 Day Supply20 mg Daily- Dose Carton Containing 6 Cards (Lenvima 0c)

FDA Label Image

Principal Display Panelndc 62856-724-30lenvima(lenvatinib) Capsules24 mg Daily Dose30 Day Supply24 mg Daily- Dose Carton Containing 6 Cards (Lenvima 0d)

FDA Label Image

Ndc 62856-704-05lenvima(lenvatinib) Capsules4 mg Daily Dose (Lenvima 0e)

FDA Label Image

Ndc 62856-708-05lenvima(lenvatinib) Capsules8 mg Daily Dose (Lenvima 0f)

A medicine called "Lenvatinib" is available in capsule form with a daily intake of 18 mg, which contains a total of 68 capsules (8 cards with 10 capsules and 1 card with 8 capsules). It is recommended to take one 10mg capsule and one 4mg capsule daily. The supplied quantity is designed for a 30-day treatment cycle.*

FDA Label Image

Ndc 62856-710-05lenvima(lenvatinib) Capsules10 mg Daily Dose (Lenvima 10)

This text appears to be a description of Lenvima capsules, which likely contain the active ingredient lenvatinib. The suggested dose is two 10mg capsules per day, and the package appears to contain a 30 day supply. However, some of the text is not readable and there may be additional important information missing.*

FDA Label Image

Ndc 62856-712-05lenvima(lenvatinib) Capsules12 mg Daily Dose (Lenvima 11)

FDA Label Image

Ndc 62856-714-05lenvima(lenvatinib) Capsules14 mg Daily Dose (Lenvima 12)

FDA Label Image

Ndc 62856-718-05lenvima(lenvatinib) Capsules18 mg Daily Dose (Lenvima 13)

FDA Label Image

Ndc 62856-720-05lenvima(lenvatinib) Capsules20 mg Daily Dose (Lenvima 14)

FDA Label Image

Ndc 62856-724-05lenvima(lenvatinib) Capsules24 mg Daily Dose (Lenvima 15)

FDA Label Image

Lenvima 16

FDA Label Image

Lenvima 17

FDA Label Image

Lenvima 18

Not available.*

FDA Label Image

Lenvima 19

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.